Stephen E. Johnson, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 6602 Knightdale Blvd, Suite 102, Knightdale, NC 27545 Phone: 919-747-5210 Fax: 919-747-5211 |
News Archive
For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 stops the immune system's B cells from doing their normal job of fighting pathogens.
In an analysis that included data on more than 10 million Medicare beneficiaries admitted to acute care hospitals with a heart attack, congestive heart failure, or pneumonia between 2002 and 2010, 30-day mortality rates for those admitted to critical access hospitals (designated hospitals that provide inpatient care to individuals living in rural communities) increased during this time period compared with patients admitted to other acute care hospitals, according to a study in the April 3 issue of JAMA.
A review of more than 200 studies reveals that olfactory receptors-proteins that bind to odors that aid the sense of smell-perform a wide range of mostly unknown functions outside the nose.
A minimally invasive technique used to destroy kidney tumors with an electrically controlled heating probe showed similar effectiveness as surgical removal of tumors in curbing cancer recurrence rates for up to five years after treatment.
As elite soldiers of the body's immune response, B cells serve as a vast standing army ready to recognize and destroy invading antigens, including infections and cancer cells. To do so, each new B cell comes equipped with its own highly specialized weapon, a unique antibody protein that selectively binds to specific parts of the antigen.
› Verified 9 days ago